These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 30272506)
1. Transdermal ethosomal gel nanocarriers; a promising strategy for enhancement of anti-hypertensive effect of carvedilol. Ibrahim TM; Abdallah MH; El-Megrab NA; El-Nahas HM J Liposome Res; 2019 Sep; 29(3):215-228. PubMed ID: 30272506 [TBL] [Abstract][Full Text] [Related]
2. Central composite design for the development of carvedilol-loaded transdermal ethosomal hydrogel for extended and enhanced anti-hypertensive effect. Amarachinta PR; Sharma G; Samed N; Chettupalli AK; Alle M; Kim JC J Nanobiotechnology; 2021 Apr; 19(1):100. PubMed ID: 33836744 [TBL] [Abstract][Full Text] [Related]
3. Upgrading of dissolution and anti-hypertensive effect of Carvedilol via two combined approaches: self-emulsification and liquisolid techniques. Ibrahim TM; Abdallah MH; El-Megrab NA; El-Nahas HM Drug Dev Ind Pharm; 2018 Jun; 44(6):873-885. PubMed ID: 29254384 [TBL] [Abstract][Full Text] [Related]
4. Ethogel topical formulation for increasing the local bioavailability of 5-fluorouracil: a mechanistic study. Puri R; Jain S Anticancer Drugs; 2012 Oct; 23(9):923-34. PubMed ID: 22926258 [TBL] [Abstract][Full Text] [Related]
6. Formulation and evaluation of the topical ethosomal gel of melatonin to prevent UV radiation. Shukla R; Tiwari G; Tiwari R; Rai AK J Cosmet Dermatol; 2020 Aug; 19(8):2093-2104. PubMed ID: 31829513 [TBL] [Abstract][Full Text] [Related]
7. Development and evaluation of carvedilol-loaded transdermal drug delivery system: In-vitro and in-vivo characterization study. Kshirsagar SJ; Bhalekar MR; Mohapatra SK Drug Dev Ind Pharm; 2012 Dec; 38(12):1530-7. PubMed ID: 22356303 [TBL] [Abstract][Full Text] [Related]
8. Application of Statistical Tooling Techniques for Designing of Carvedilol Nanolipid Transferosomes and its Dermatopharmacokinetic and Pharmacodynamic Studies. Selvaraj BR; Sridhar SK; Kesavan BR; Palagati S Pharm Nanotechnol; 2020; 8(6):452-470. PubMed ID: 32988361 [TBL] [Abstract][Full Text] [Related]
9. Design by optimization and comparative evaluation of vesicular gels of etodolac for transdermal delivery. Madhavi N; Sudhakar B; Reddy KVNS; Ratna JV Drug Dev Ind Pharm; 2019 Apr; 45(4):611-628. PubMed ID: 30712433 [TBL] [Abstract][Full Text] [Related]
10. Transdermal lipid vesicular delivery of iloperidone: Formulation, in vitro and in vivo evaluation. Londhe VY; Bhasin B Colloids Surf B Biointerfaces; 2019 Nov; 183():110409. PubMed ID: 31386933 [TBL] [Abstract][Full Text] [Related]
11. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes. Dubey V; Mishra D; Dutta T; Nahar M; Saraf DK; Jain NK J Control Release; 2007 Nov; 123(2):148-54. PubMed ID: 17884226 [TBL] [Abstract][Full Text] [Related]
12. Karanjin-loaded soya lecithin-based ethosomal nanogel for the therapeutic intervention of psoriasis: formulation development, factorial design based-optimization, Mujtaba MA; Gangane P; Ali A; Chaudhari S; Kaleem M; More S; Shahzad N; Elhassan GO; Anwer MK Biomed Mater; 2024 Jul; 19(5):. PubMed ID: 38955335 [TBL] [Abstract][Full Text] [Related]
13. Formulation of niosomal gel for enhanced transdermal lopinavir delivery and its comparative evaluation with ethosomal gel. Patel KK; Kumar P; Thakkar HP AAPS PharmSciTech; 2012 Dec; 13(4):1502-10. PubMed ID: 23104306 [TBL] [Abstract][Full Text] [Related]
14. Quality by design approach for formulation, evaluation and statistical optimization of diclofenac-loaded ethosomes via transdermal route. Jain S; Patel N; Madan P; Lin S Pharm Dev Technol; 2015 Jun; 20(4):473-89. PubMed ID: 24490793 [TBL] [Abstract][Full Text] [Related]
15. Transdermal glimepiride delivery system based on optimized ethosomal nano-vesicles: Preparation, characterization, in vitro, ex vivo and clinical evaluation. Ahmed TA; El-Say KM; Aljaeid BM; Fahmy UA; Abd-Allah FI Int J Pharm; 2016 Mar; 500(1-2):245-54. PubMed ID: 26775063 [TBL] [Abstract][Full Text] [Related]
16. Ethosomal Gel for Improving Transdermal Delivery of Thymosin β-4. Fu X; Shi Y; Wang H; Zhao X; Sun Q; Huang Y; Qi T; Lin G Int J Nanomedicine; 2019; 14():9275-9284. PubMed ID: 31819429 [TBL] [Abstract][Full Text] [Related]
17. Formulation and Characterization of Nanosized Ethosomal Formulations of Antigout Model Drug (Febuxostat) Prepared by Cold Method: In Vitro/Ex Vivo and In Vivo Assessment. El-Shenawy AA; Abdelhafez WA; Ismail A; Kassem AA AAPS PharmSciTech; 2019 Dec; 21(1):31. PubMed ID: 31858305 [TBL] [Abstract][Full Text] [Related]
18. Quality by Design for Development, Optimization and Characterization of Brucine Ethosomal Gel for Skin Cancer Delivery. Ismail TA; Shehata TM; Mohamed DI; Elsewedy HS; Soliman WE Molecules; 2021 Jun; 26(11):. PubMed ID: 34200144 [TBL] [Abstract][Full Text] [Related]
19. Formulation Optimization and In-vitro and In-vivo Evaluation of Lornoxicam Ethosomal Gels with Penetration Enhancers. Li K; Gao S; Tian B; Shi Y; Lv Q; Han J Curr Drug Deliv; 2018; 15(3):424-435. PubMed ID: 29219057 [TBL] [Abstract][Full Text] [Related]
20. In vitro permeation of carvedilol through porcine skin: effect of vehicles and penetration enhancers. Gannu R; Vishnu YV; Kishan V; Rao YM PDA J Pharm Sci Technol; 2008; 62(4):256-63. PubMed ID: 19174954 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]